1. Home
  2. ENTA vs ACNT Comparison

ENTA vs ACNT Comparison

Compare ENTA & ACNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENTA
  • ACNT
  • Stock Information
  • Founded
  • ENTA 1995
  • ACNT 1945
  • Country
  • ENTA United States
  • ACNT United States
  • Employees
  • ENTA N/A
  • ACNT N/A
  • Industry
  • ENTA Biotechnology: Pharmaceutical Preparations
  • ACNT Steel/Iron Ore
  • Sector
  • ENTA Health Care
  • ACNT Industrials
  • Exchange
  • ENTA Nasdaq
  • ACNT Nasdaq
  • Market Cap
  • ENTA 112.4M
  • ACNT 118.8M
  • IPO Year
  • ENTA 2013
  • ACNT N/A
  • Fundamental
  • Price
  • ENTA $5.93
  • ACNT $12.92
  • Analyst Decision
  • ENTA Buy
  • ACNT
  • Analyst Count
  • ENTA 4
  • ACNT 0
  • Target Price
  • ENTA $17.25
  • ACNT N/A
  • AVG Volume (30 Days)
  • ENTA 119.2K
  • ACNT 111.0K
  • Earning Date
  • ENTA 05-12-2025
  • ACNT 05-12-2025
  • Dividend Yield
  • ENTA N/A
  • ACNT N/A
  • EPS Growth
  • ENTA N/A
  • ACNT N/A
  • EPS
  • ENTA N/A
  • ACNT N/A
  • Revenue
  • ENTA $64,462,999.00
  • ACNT $174,652,000.00
  • Revenue This Year
  • ENTA N/A
  • ACNT $22.72
  • Revenue Next Year
  • ENTA N/A
  • ACNT N/A
  • P/E Ratio
  • ENTA N/A
  • ACNT N/A
  • Revenue Growth
  • ENTA N/A
  • ACNT 5.04
  • 52 Week Low
  • ENTA $4.09
  • ACNT $8.16
  • 52 Week High
  • ENTA $17.24
  • ACNT $13.33
  • Technical
  • Relative Strength Index (RSI)
  • ENTA 55.39
  • ACNT 57.05
  • Support Level
  • ENTA $5.55
  • ACNT $12.46
  • Resistance Level
  • ENTA $6.23
  • ACNT $12.72
  • Average True Range (ATR)
  • ENTA 0.33
  • ACNT 0.39
  • MACD
  • ENTA 0.05
  • ACNT 0.03
  • Stochastic Oscillator
  • ENTA 75.31
  • ACNT 95.42

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

About ACNT Ascent Industries Co.

Ascent Industries Co is engaged in the chemical and metal industry. The group operates into two reportable segments namely the Specialty Chemicals and Tubular Products. The Tubular Products segment serves markets through pipe and tube and customers in the appliance, architectural, automotive, and commercial transportation, brewery, chemical, petrochemical, and other industries. The Specialty Chemicals segment produces specialty products for pulp and paper, coatings, adhesives, sealants, and elastomers (CASE), textile, automotive, household, and other industries. It manufactures welded pipe and tube, majorly from stainless steel, duplex, and nickel alloys. The company also produces specialty chemicals and dyes used in various end markets.

Share on Social Networks: